Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials

Acute Exacerbations of Chronic Obstructive Pulmonary Disease: Identification of Biologic Clusters and Their Biomarkers

Mona Bafadhel, Susan McKenna, Sarah Terry et al. · American Journal of Respiratory and Critical Care Medicine · 2011 · 1.1K citations

Medicine, Clinical Sciences, Internal Medicine +17

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Jadwiga A. Wedzicha, Donald Banerji, Kenneth R. Chapman et al. · New England Journal of Medicine · 2016 · 870 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials

Steven Pascoe, Nicholas Locantore, Mark T. Dransfield et al. · The Lancet Respiratory Medicine · 2015 · 733 citations

Medicine, Clinical Sciences, Pharmacotherapy +17

Blood Eosinophils to Direct Corticosteroid Treatment of Exacerbations of Chronic Obstructive Pulmonary Disease: A Randomized Placebo-Controlled Trial

Mona Bafadhel, Susan McKenna, Sarah Terry et al. · American Journal of Respiratory and Critical Care Medicine · 2012 · 607 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease

Ian Pavord, Pascal Chanez, Gerard J. Criner et al. · New England Journal of Medicine · 2017 · 591 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14